Index of /wp-content/uploads/2024/12
Name
Last modified
Size
Description
Parent Directory
-
sodium-valproate-associated-psoriasis-24cr03803.pdf
2024-12-28 18:12
5.9M
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507.pdf
2024-12-20 12:10
4.2M
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768.pdf
2024-12-17 11:50
3.7M
treatments-predictors-substance-use-disorders-attention-deficit-hyperactivity-disorder-INCAS-24m15494.pdf
2024-12-18 06:11
3.6M
long-term-safety-tolerability-treatment-effect-olanzapine-samidorphan-4-year-open-label-study-24m15511.pdf
2024-12-04 14:48
3.5M
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-Table1.pdf
2024-12-20 17:29
3.4M
alzheimers-dementia-FDG-PET-neuropsychological-24cr03752.pdf
2024-12-12 11:04
3.2M
educational-intervention-mental-health-competency-24m03777.pdf
2024-12-02 08:46
3.1M
cannabis-use-pregnancy-neuropsychiatric-adverse-outcomes-children-young-adults-24f15753.pdf
2024-12-27 04:43
2.9M
Sex-Differences-PTSD-US-Military-Veterans-trauma-coping-social-factors-24br15621.pdf
2024-12-14 05:21
2.8M
opioid-industrys-legacy-generation-prescribed-suffering-24com15664.pdf
2024-12-14 12:04
2.8M
catatonia-post-acute-covid-19-young-child-24cr03796.pdf
2024-12-27 04:56
2.7M
discord-cyberbullying-adolescent-mental-health-24cr03797.pdf
2024-12-14 06:00
2.7M
rash-hypersensitivity-bupropion-24cr03788.pdf
2024-12-28 18:12
2.6M
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339.pdf
2024-12-20 10:46
2.4M
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-1.pdf
2024-12-28 18:12
2.1M
evolution-treatment-modalities-PTSD-24nr03767.pdf
2024-12-11 10:12
2.1M
trichotillomania-tele-based-habit-reversal-therapy-24cr03785.pdf
2024-12-26 09:07
1.5M
affective-behavioral-cognitive-focal-impaired-awareness-seizures-24f03813.pdf
2024-12-19 06:25
1.3M
maternal-cannabis-use-pregnancy-autism-spectrum-disorder-attention-deficit-hyperactivity-disorder-offspring-24f15717.pdf
2024-12-18 06:33
1.2M
combined-cyproheptadine-dexamethasone-dependence-24cr03731.pdf
2024-12-09 11:55
1.1M
fluctuating-impairment-complex-presentations-evolving-care-research-priorities-ADHD-24com15705.pdf
2024-12-18 05:29
1.0M
differential-diagnoses-catatonia-clozapine-withdrawal-24cr03787.pdf
2024-12-18 04:59
900K
antipsychotic-induced-tardive-lingual-dystonia-bradycardia-24cr03781.pdf
2024-12-17 07:11
886K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t1-2048x1637.png
2024-12-28 18:12
590K
evolution-treatment-modalities-PTSD-Table1-24nr03767.pdf
2024-12-11 22:37
581K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t3-2048x1404.png
2024-12-28 18:12
509K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f2-2048x2014.png
2024-12-28 18:12
419K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t1-1536x1227.png
2024-12-28 18:12
412K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t2-2048x1254.png
2024-12-28 18:12
401K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-SM.pdf
2024-12-20 17:08
391K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t1.png
2024-12-17 11:49
363K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t3-1536x1053.png
2024-12-28 18:12
358K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t2-2048x1612.png
2024-12-18 10:26
321K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-t1-1884x2048.png
2024-12-20 12:03
303K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f1-1266x2048.png
2024-12-28 18:12
302K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f1.png
2024-12-20 12:03
294K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f2-1536x1510.png
2024-12-28 18:12
290K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t1-2048x1499.png
2024-12-17 11:49
290K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-t1-1413x1536.png
2024-12-20 12:03
282K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t2-1536x941.png
2024-12-28 18:12
280K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f1-2048x1835.png
2024-12-20 12:03
276K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t1-1024x818.png
2024-12-28 18:12
245K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t3-1238x2048.png
2024-12-20 10:46
240K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-f1-1536x1204.png
2024-12-17 11:49
224K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t3-1024x702.png
2024-12-28 18:12
219K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t1-1536x1124.png
2024-12-17 11:49
210K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f1-949x1536.png
2024-12-28 18:12
209K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f1-1536x1376.png
2024-12-20 12:03
203K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t1-2048x1432.png
2024-12-18 10:26
193K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t2.png
2024-12-18 10:26
185K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t1.png
2024-12-20 10:46
183K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f2-1024x1007.png
2024-12-28 18:12
175K
differential-diagnoses-catatonia-clozapine-withdrawal-24cr03787-f1-2048x1828.png
2024-12-18 11:52
174K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-f1-1021x2048.png
2024-12-20 10:46
174K
evolution-treatment-modalities-PTSD-24nr03767-t1-969x2048.png
2024-12-11 11:52
173K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t2-1024x627.png
2024-12-28 18:12
169K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t1-768x614.png
2024-12-28 18:12
167K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f1-768x1243.png
2024-12-28 18:12
158K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t2-1536x1209.png
2024-12-18 10:26
154K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t3-768x526.png
2024-12-28 18:12
152K
300x446_SFDTD1.png
2024-12-29 03:08
150K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t3-2048x980.png
2024-12-18 12:27
148K
evolution-treatment-modalities-PTSD-24nr03767-t1-768x1623.png
2024-12-11 11:52
146K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t1-2048x1105.png
2024-12-18 12:24
145K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t1-1048x2048.png
2024-12-20 10:46
143K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t1.png
2024-12-18 10:26
139K
alzheimers-dementia-FDG-PET-neuropsychological-24cr03752-t1-2048x772.png
2024-12-16 11:23
139K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f2-1505x2048.png
2024-12-20 12:03
136K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t3-928x1536.png
2024-12-20 10:46
136K
IMG_0069.jpeg
2024-12-10 16:55
133K
evolution-treatment-modalities-PTSD-24nr03767-t1-727x1536.png
2024-12-11 11:52
132K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f4-2048x1240.png
2024-12-20 12:03
131K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f3-1536x984.png
2024-12-20 12:03
131K
alzheimers-dementia-FDG-PET-neuropsychological-24cr03752-t1.png
2024-12-16 11:23
130K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t1-1536x829.png
2024-12-18 12:24
129K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f3-2048x1311.png
2024-12-20 12:03
129K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f1-633x1024.png
2024-12-28 18:12
125K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t1.png
2024-12-30 18:43
122K
PCC_Mental-health-competency.jpg
2024-12-09 19:58
122K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f2.png
2024-12-20 12:03
122K
PCC_Combined-Cyproheptadine-Dexamethasone-Dependence.jpg
2024-12-30 18:45
121K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f2-768x755.png
2024-12-28 18:12
121K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t1-1024x749.png
2024-12-17 11:49
120K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t2-768x470.png
2024-12-28 18:12
120K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t1-600x479.png
2024-12-28 18:12
119K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t2-2048x889.png
2024-12-18 12:27
118K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t2-1024x806.png
2024-12-18 10:26
118K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f1-600x971.png
2024-12-28 18:12
116K
PCC_C1_v26-6.png
2024-12-30 16:21
115K
Sex-Differences-PTSD-US-Military-Veterans-trauma-coping-social-factors-24br15621-t1-768x1007.png
2024-12-14 12:24
115K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t3.png
2024-12-20 10:46
114K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t1-786x1536.png
2024-12-20 10:46
113K
1200x800_FoP_Call11.png
2024-12-29 03:00
113K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t1-1536x1074.png
2024-12-18 10:26
113K
JCP_Sex-Differences-in-PTSD-1.jpg
2024-12-16 03:00
113K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f4-928x2048.png
2024-12-03 08:51
112K
IMG_0069-scaled.jpeg
2024-12-10 16:55
112K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t3-600x411.png
2024-12-28 18:12
111K
differential-diagnoses-catatonia-clozapine-withdrawal-24cr03787-f1-1536x1371.png
2024-12-18 11:52
111K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f2.png
2024-12-30 18:43
109K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t3-1536x735.png
2024-12-18 12:27
107K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t3-768x1271.png
2024-12-20 10:46
107K
Sex-Differences-PTSD-US-Military-Veterans-trauma-coping-social-factors-24br15621-t1-781x1024.png
2024-12-14 12:24
107K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t2-2048x899.png
2024-12-20 10:46
105K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f3.png
2024-12-20 12:03
105K
JCP_Memantine-for-ADHD.jpg
2024-12-18 15:49
104K
PCC_Diamond1.png
2024-12-29 03:42
101K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-f1-768x1541.png
2024-12-20 10:46
101K
PCC_Mental-health-competency-1024x683.jpg
2024-12-09 19:58
99K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-t1.png
2024-12-30 18:44
99K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t1-768x1501.png
2024-12-20 10:46
99K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f4-1536x930.png
2024-12-20 12:03
99K
12-13-24_dogs.jpeg
2025-04-08 15:30
97K
JCP_Substance-use-and-ADHD.jpg
2024-12-18 15:49
97K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f4.png
2024-12-20 12:03
96K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f1-768x688.png
2024-12-20 12:03
96K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-t1-942x1024.png
2024-12-20 12:03
94K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f1-1024x918.png
2024-12-20 12:03
94K
JCP_care-and-research-in-ADHD.jpg
2024-12-30 18:44
93K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t1.png
2024-12-18 12:24
93K
PCC_BD-and-PTSD.jpg
2025-04-08 15:56
93K
combined-cyproheptadine-dexamethasone-dependence-24cr03731-t1-1024x650.png
2024-12-09 11:55
93K
12-1824_PTSD.jpeg
2025-04-08 15:01
92K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-f1.png
2024-12-17 11:49
92K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f1.png
2024-12-30 18:43
92K
12-20-24_Overpackaging.jpeg
2025-04-09 09:00
91K
JCP_Sex-Differences-in-PTSD-1-1024x684.jpg
2024-12-16 03:00
91K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-f1-766x1536.png
2024-12-20 10:46
91K
PCC_Combined-Cyproheptadine-Dexamethasone-Dependence-1024x683.jpg
2024-12-09 18:25
91K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t3-619x1024.png
2024-12-20 10:46
89K
differential-diagnoses-catatonia-clozapine-withdrawal-24cr03787-f1.png
2024-12-18 11:52
89K
JCP_Sex-Differences-in-Antidepressant-Acceptability.jpg
2024-12-03 22:32
89K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f2-600x590.png
2024-12-28 18:12
89K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f2-1024x533.png
2024-12-03 08:52
87K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t2-600x367.png
2024-12-28 18:12
87K
12-23-24_Holidays.jpeg
2025-04-08 20:16
86K
800x892-PsychCase360-BP1.png
2024-12-29 03:08
86K
IMG_0069-1024x680.jpeg
2024-12-10 16:55
85K
PCC_Tardive-Lingual-Dystonia.jpg
2024-12-20 16:49
85K
evolution-treatment-modalities-PTSD-24nr03767-t2-1024x699.png
2024-12-11 11:52
85K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t2-1536x674.png
2024-12-20 10:46
85K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t2-1536x667.png
2024-12-18 12:27
85K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t3.png
2024-12-18 12:27
84K
JCP_Memantine-for-ADHD-1024x684.jpg
2024-12-18 15:49
84K
educational-intervention-mental-health-competency-24m03777-t1-1024x897.png
2024-12-02 10:43
83K
evolution-treatment-modalities-PTSD-24nr03767-t1.png
2024-12-30 18:45
83K
12-02-24_Trauma.jpg
2024-12-30 18:45
82K
Sex-Differences-PTSD-US-Military-Veterans-trauma-coping-social-factors-24br15621-t1.png
2024-12-14 12:24
82K
JCP_Substance-use-and-ADHD-1024x683.jpg
2024-12-18 15:49
82K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f4-696x1536.png
2024-12-03 08:51
81K
alzheimers-dementia-FDG-PET-neuropsychological-24cr03752-t1-1536x579.png
2024-12-16 11:23
79K
PCC_Cyberbullying-and-Adolescent-MH.jpg
2024-12-20 16:49
79K
JCP_C1_85-4.png
2024-12-30 16:01
78K
PCC_BD-and-PTSD-1024x684.jpg
2024-12-20 16:49
77K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t2-1536x891.png
2024-12-17 11:49
77K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f4-768x1696.png
2024-12-03 08:51
77K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t1-1024x716.png
2024-12-18 10:26
76K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-f1.png
2024-12-20 10:46
76K
JCP_care-and-research-in-ADHD-1024x683.jpg
2024-12-18 15:49
75K
12-13-24_dogs-768x468.jpeg
2024-12-13 17:45
75K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-f1-1024x803.png
2024-12-17 11:49
74K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t3.png
2024-12-30 18:43
74K
evolution-treatment-modalities-PTSD-24nr03767-t1-485x1024.png
2024-12-11 11:52
74K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f2-1128x1536.png
2024-12-20 12:03
73K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t1-768x562.png
2024-12-17 11:49
73K
600x892_Sleep-Suicide1.png
2024-12-29 03:08
73K
educational-intervention-mental-health-competency-24m03777-t1-768x673.png
2024-12-02 10:43
73K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-SM.pdf
2024-12-03 09:47
73K
educational-intervention-mental-health-competency-24m03777-f1-504x1024.png
2024-12-02 10:43
72K
JCP_Sex-Differences-in-Antidepressant-Acceptability-1024x684.jpg
2024-12-03 22:32
72K
PCC_hypersensitivity-bupriopion.jpg
2024-12-11 23:42
72K
12-03.24_Schizophrenia.jpeg
2025-04-08 18:05
70K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t2-768x605.png
2024-12-18 10:26
70K
PCC_Cyberbullying-and-Adolescent-MH-1024x683.jpg
2024-12-20 16:49
70K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-f1-510x1024.png
2024-12-20 10:46
70K
JCP_Kornstein1.jpg
2024-12-29 03:26
70K
JCP_Swartz1.jpg
2024-12-29 03:32
69K
12-20-24_Overpackaging-768x512.jpeg
2024-12-20 16:58
69K
JCP_Rapaport1.jpg
2024-12-29 03:29
69K
12-16-24_PTSD.jpeg
2024-12-30 18:44
69K
12-1824_PTSD-768x512.jpeg
2024-12-18 17:34
68K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t2-2048x1189.png
2024-12-17 11:49
68K
12-23-24_Holidays-768x512.jpeg
2024-12-23 19:49
67K
JCP_Keuroghlian1.jpg
2024-12-29 03:25
67K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-f1-2048x1605.png
2024-12-17 11:49
67K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t1-1024x553.png
2024-12-18 12:24
67K
differential-diagnoses-catatonia-clozapine-withdrawal-24cr03787-f1-1024x914.png
2024-12-18 11:52
66K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t1-768x537.png
2024-12-18 10:26
66K
JCP_Andrade1.jpg
2024-12-29 03:23
66K
JCP_Schooler1.jpg
2024-12-29 03:31
66K
JCP_Schooler1-1.jpg
2024-12-29 03:31
66K
PCC_Mental-health-competency-768x512.jpg
2024-12-09 19:58
64K
PCC_Tardive-Lingual-Dystonia-1024x683.jpg
2024-12-20 16:49
64K
12-5-24_Depression.jpeg
2024-12-30 18:45
64K
JCP_Long-Term-Safety-Olanzapine-and-Samidorphan.jpg
2024-12-03 22:36
63K
PCC_Farinde1.jpg
2024-12-29 03:42
63K
12-02-24_Trauma-768x432.jpg
2024-12-02 20:05
63K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t2.png
2024-12-18 12:27
62K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t2.png
2024-12-30 18:43
62K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t2.png
2024-12-20 10:46
61K
PCC_hypersensitivity-bupriopion-1024x684.jpg
2024-12-11 23:42
61K
JCP_Opioid-Industry-Legacy-1.jpg
2024-12-16 03:00
61K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t3-1024x490.png
2024-12-18 12:27
60K
12-11-24_PTSD.jpeg
2024-12-30 18:45
60K
PCC_Jolly1.jpg
2024-12-29 03:44
60K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-t1-768x835.png
2024-12-20 12:03
60K
JCP_Sex-Differences-in-PTSD-1-768x513.jpg
2024-12-16 03:00
59K
PCC_Evolution-of-Treatment-for-PTSD.jpg
2024-12-09 18:25
59K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f3-1024x656.png
2024-12-20 12:03
59K
JCP_Fava1.jpg
2024-12-29 03:25
58K
PCC_Combined-Cyproheptadine-Dexamethasone-Dependence-768x512.jpg
2024-12-09 18:25
58K
JCP_Rothbaum1.jpg
2024-12-29 03:30
58K
JCP_Rothbaum1-1.jpg
2024-12-29 03:31
58K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t1-524x1024.png
2024-12-20 10:46
58K
PCC_Trinh1.jpg
2024-12-29 03:46
56K
JCP_Clark1.jpg
2024-12-29 03:24
56K
PCC_Alzheimer-Dementia-FDG-PET.jpg
2024-12-16 03:00
55K
12-12-24_Schizophrenia.jpeg
2024-12-30 18:45
55K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f4.png
2024-12-03 08:51
54K
JCP_Memantine-for-ADHD-768x513.jpg
2024-12-18 15:49
54K
JCP_Substance-use-and-ADHD-768x512.jpg
2024-12-18 15:49
54K
educational-intervention-mental-health-competency-24m03777-f1.png
2024-12-02 10:43
53K
JCP_Courtet1.jpg
2024-12-29 03:20
53K
IMG_0069-768x510.jpeg
2024-12-10 16:55
52K
12-16-24_PTSD-768x512.jpeg
2024-12-16 19:44
52K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t2-1024x449.png
2024-12-20 10:46
52K
12-19-24_Discipline.jpeg
2024-12-19 16:22
51K
JCP_Freeman-11.jpg
2024-12-29 03:19
51K
JCP_Cohen1.jpg
2024-12-29 03:24
51K
Notice-of-Retraction-Gawash-PCC.24lr03900.pdf
2024-12-09 23:32
51K
PCC_BD-and-PTSD-768x513.jpg
2024-12-20 16:49
50K
JCP_Long-Term-Safety-Olanzapine-and-Samidorphan-1024x683.jpg
2024-12-03 22:36
50K
PCC_Alzheimer-Dementia-FDG-PET-1024x683.jpg
2024-12-16 03:00
50K
12-5-24_Depression-768x512.jpeg
2024-12-05 17:28
49K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f2-768x1045.png
2024-12-20 12:03
49K
JCP_Greist1.jpg
2024-12-29 03:25
49K
12-03.24_Schizophrenia-768x614.jpeg
2024-12-03 16:58
48K
JCP_care-and-research-in-ADHD-768x512.jpg
2024-12-18 15:49
48K
JCP_Sex-Differences-in-Antidepressant-Acceptability-768x513.jpg
2024-12-03 22:32
47K
evolution-treatment-modalities-PTSD-24nr03767-t2-768x524.png
2024-12-11 11:52
47K
JCP_Wilkinson1.jpg
2024-12-29 03:33
47K
JCP_Moreno1.jpg
2024-12-29 03:27
47K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-f1-768x602.png
2024-12-17 11:49
47K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t1-300x300.png
2024-12-28 18:12
46K
12-11-24_PTSD-768x512.jpeg
2024-12-11 16:51
46K
PCC_Weisberg1.jpg
2024-12-29 03:47
46K
educational-intervention-mental-health-competency-24m03777-t1.png
2024-12-02 10:43
46K
PCC_Jain1.jpg
2024-12-29 03:43
46K
JCP_Wagner1.jpg
2024-12-29 03:22
46K
JCP_Nierenberg1.jpg
2024-12-29 03:28
46K
JCP_Meyer1.jpg
2024-12-29 03:27
46K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t3-300x300.png
2024-12-28 18:12
45K
PCC_Evolution-of-Treatment-for-PTSD-1024x683.jpg
2024-12-09 18:25
45K
PCC_Cyberbullying-and-Adolescent-MH-768x512.jpg
2024-12-20 16:49
45K
PCC_Connor1.jpeg
2024-12-29 03:41
45K
JCP_Rosenbaum1.jpg
2024-12-29 03:30
45K
combined-cyproheptadine-dexamethasone-dependence-24cr03731-t1-768x487.png
2024-12-09 11:55
45K
12-4-24_Music.jpeg
2024-12-04 18:14
45K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t1-768x414.png
2024-12-18 12:24
45K
JCP_Saunders1.jpg
2024-12-29 03:31
44K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f3-1024x833.png
2024-12-03 08:51
44K
12-9-24_PTSD.jpeg
2025-04-08 15:30
44K
PCC_Tynes1.jpg
2024-12-29 03:46
44K
JCP_Thase1.jpg
2024-12-29 03:33
44K
PCC_Felker1.jpg
2024-12-29 03:43
44K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t3-300x206.png
2024-12-28 18:12
43K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f4-1024x620.png
2024-12-20 12:03
43K
PCC_McCarron1.jpg
2024-12-29 03:45
43K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t1-300x240.png
2024-12-28 18:12
43K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f3-768x492.png
2024-12-20 12:03
43K
PCC_Rado1.jpg
2024-12-29 03:45
43K
PCC_Ling1.jpg
2024-12-29 03:44
42K
JCP_Lee1.jpg
2024-12-29 03:26
42K
12-12-24_Schizophrenia-768x512.jpeg
2024-12-12 15:51
42K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f3-768x625.png
2024-12-03 08:51
42K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t2.png
2024-12-17 11:49
42K
JCP_Zimmerman1.jpg
2024-12-29 03:34
41K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f2-752x1024.png
2024-12-20 12:03
41K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t3-768x367.png
2024-12-18 12:27
41K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t2-1024x445.png
2024-12-18 12:27
41K
JCP_McElroy1.jpg
2024-12-29 03:27
41K
12-19-24_Discipline-768x432.jpeg
2024-12-19 16:22
41K
JCP_Preskorn1.jpg
2024-12-29 03:29
40K
JCP_Rothschild1.jpg
2024-12-30 23:18
40K
alzheimers-dementia-FDG-PET-neuropsychological-24cr03752-t1-1024x386.png
2024-12-16 11:23
40K
PCC_Susman1.jpg
2024-12-29 03:46
40K
JCP_Markowitz1.jpg
2024-12-29 03:21
40K
differential-diagnoses-catatonia-clozapine-withdrawal-24cr03787-f1-768x686.png
2024-12-18 11:52
40K
PCC_Wulsin1.jpg
2024-12-29 03:47
40K
PCC_hypersensitivity-bupriopion-768x513.jpg
2024-12-11 23:42
39K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f4-768x465.png
2024-12-20 12:03
39K
PCC_Masand1.jpg
2024-12-29 03:44
39K
JCP_Small1.jpg
2024-12-29 03:22
39K
JCP_Opioid-Industry-Legacy-1-1024x683.jpg
2024-12-16 03:00
39K
PCC_Tardive-Lingual-Dystonia-768x512.jpg
2024-12-20 16:49
38K
PCC_Brown1.jpg
2024-12-29 03:42
38K
JCP_Papakostas1.jpg
2024-12-29 03:28
38K
PCC_Rush1.jpg
2024-12-29 03:31
38K
PCC_Rush1-1.jpg
2024-12-29 03:45
38K
JCP_Pederson1.jpg
2024-12-29 03:29
37K
JCP_Balon1.jpg
2024-12-29 03:36
37K
JCP_Goldberg1.jpg
2024-12-29 03:20
37K
educational-intervention-mental-health-competency-24m03777-t2-1024x521.png
2024-12-02 10:43
37K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f2-300x300.png
2024-12-28 18:12
37K
JCP_Shinn1.jpg
2024-12-29 03:22
36K
JCP_Shinn1-1.jpg
2024-12-29 03:32
36K
educational-intervention-mental-health-competency-24m03777-f1-300x609.png
2024-12-02 10:43
36K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f4-464x1024.png
2024-12-03 08:51
36K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f1-1024x470.png
2024-12-03 08:52
36K
12-16-24_post-partum-depression.jpeg
2024-12-30 18:44
36K
JCP_Karp1.jpg
2024-12-29 03:21
35K
PCC_Pollack1.jpg
2024-12-29 03:29
35K
PCC_Pollack1-1.jpg
2024-12-29 03:45
35K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f2-300x295.png
2024-12-28 18:12
35K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t2-300x184.png
2024-12-28 18:12
35K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t2-300x300.png
2024-12-28 18:12
35K
12-4-24_Music-768x576.jpeg
2024-12-04 18:14
34K
12-9-24_PTSD-768x456.jpeg
2024-12-09 18:38
34K
600x892_Alzheimer1.png
2024-12-29 03:07
34K
JCP_McIntyre1.jpg
2024-12-29 03:27
34K
PCC_Jackson1.jpg
2024-12-29 03:43
34K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t2-768x337.png
2024-12-20 10:46
34K
PCC_Findling1.jpg
2024-12-29 03:43
33K
JCP_Long-Term-Safety-Olanzapine-and-Samidorphan-768x512.jpg
2024-12-03 22:36
33K
JCP_Ostacher1.jpg
2024-12-29 03:28
33K
combined-cyproheptadine-dexamethasone-dependence-24cr03731-t1.png
2024-12-09 11:55
33K
PCC_Alzheimer-Dementia-FDG-PET-768x512.jpg
2024-12-16 03:00
33K
PCC_Lipkin1.jpg
2024-12-29 03:44
32K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f1-768x352.png
2024-12-03 08:52
32K
JCP_Nelson1.jpg
2024-12-29 03:28
32K
JCP_Vanderkruik1.jpg
2024-12-29 03:22
32K
evolution-treatment-modalities-PTSD-24nr03767-t1-300x634.png
2024-12-11 11:52
32K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-f1-300x602.png
2024-12-20 10:46
31K
PCC_deGruy.jpg
2024-12-30 14:52
31K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t2-768x333.png
2024-12-18 12:27
31K
PCC_Culpepper-3001.png
2024-12-29 03:40
31K
evolution-treatment-modalities-PTSD-24nr03767-t2.png
2024-12-11 11:52
30K
PCC_Evolution-of-Treatment-for-PTSD-768x512.jpg
2024-12-09 18:25
29K
12-16-24_post-partum-depression-768x527.jpeg
2024-12-16 15:16
29K
Image.jpeg
2024-12-17 16:05
28K
evolution-treatment-modalities-PTSD-24nr03767-t3-1024x279.png
2024-12-11 11:52
28K
JCP_Wisner1.jpg
2024-12-29 03:33
28K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t2-1024x594.png
2024-12-17 11:49
27K
JCP_Rhee1.jpg
2024-12-29 03:30
27K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f2-768x400.png
2024-12-03 08:52
27K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t3-300x496.png
2024-12-20 10:46
27K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t1-300x586.png
2024-12-20 10:46
26K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f3.png
2024-12-03 08:51
26K
alzheimers-dementia-FDG-PET-neuropsychological-24cr03752-t1-768x290.png
2024-12-16 11:23
26K
educational-intervention-mental-health-competency-24m03777-t2-768x391.png
2024-12-02 10:43
26K
278x413-house4pack.png
2025-01-20 22:28
25K
JCP_Maj1.jpg
2024-12-29 03:26
25K
JCP_Opioid-Industry-Legacy-1-768x512.jpg
2024-12-16 03:00
25K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t2-768x446.png
2024-12-17 11:49
25K
JCP_Weiss1.jpg
2024-12-29 03:33
24K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f1-300x300.png
2024-12-28 18:12
23K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f1-185x300.png
2024-12-28 18:12
23K
Sex-Differences-PTSD-US-Military-Veterans-trauma-coping-social-factors-24br15621-t1-300x393.png
2024-12-14 12:24
22K
278x413-Biostats.png
2025-01-20 22:32
22K
Image-scaled.jpeg
2024-12-17 16:05
21K
educational-intervention-mental-health-competency-24m03777-t2.png
2024-12-02 10:43
20K
evolution-treatment-modalities-PTSD-24nr03767-t3-768x209.png
2024-12-11 11:52
20K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f4-300x662.png
2024-12-03 08:51
19K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-t1-300x396.png
2024-12-03 08:52
19K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-t1.png
2024-12-03 08:52
19K
Image-1024x576.jpeg
2024-12-17 16:05
18K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f1-300x485.png
2024-12-20 16:59
17K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t3-150x150.png
2024-12-28 18:12
17K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f1.png
2024-12-03 08:52
17K
12-23-24_Holidays-300x200.jpeg
2024-12-23 19:49
17K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f1-300x269.png
2024-12-20 12:03
17K
PCC_Manning-3001.jpg
2024-12-29 03:40
16K
PCC_Manning-3001-1.jpg
2024-12-29 03:40
16K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t2-300x236.png
2024-12-18 10:26
16K
PCC_Mental-health-competency-300x200.jpg
2024-12-09 19:58
16K
12-1824_PTSD-300x200.jpeg
2024-12-18 17:34
16K
12-13-24_dogs-300x183.jpeg
2024-12-13 17:45
16K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t1-150x150.png
2024-12-28 18:12
15K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-t2.png
2024-12-03 08:51
15K
12-02-24_Trauma-300x169.jpg
2024-12-02 20:05
15K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f2.png
2024-12-03 08:52
15K
12-20-24_Overpackaging-300x200.jpeg
2024-12-20 16:58
15K
educational-intervention-mental-health-competency-24m03777-t1-300x263.png
2024-12-02 10:43
15K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t1-300x220.png
2024-12-17 11:49
15K
Sex-Differences-PTSD-US-Military-Veterans-trauma-coping-social-factors-24br15621-t1-229x300.png
2024-12-14 12:24
14K
JCP_Sex-Differences-in-PTSD-1-300x200.jpg
2024-12-16 03:00
14K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-t2-300x344.png
2024-12-03 08:51
14K
PCC_Combined-Cyproheptadine-Dexamethasone-Dependence-300x200.jpg
2024-12-09 18:25
14K
JCP_Substance-use-and-ADHD-300x200.jpg
2024-12-18 15:49
14K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f2-300x408.png
2024-12-20 12:03
14K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t2-150x150.png
2024-12-28 18:12
14K
PCC_BD-and-PTSD-300x200.jpg
2024-12-20 16:49
13K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t1-300x210.png
2024-12-18 10:26
13K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f2-150x150.png
2024-12-28 18:12
13K
278x413-house4pack-schizophrenia.png
2024-12-30 17:04
13K
12-5-24_Depression-300x200.jpeg
2024-12-05 17:28
13K
12-16-24_PTSD-300x200.jpeg
2024-12-16 19:44
12K
Image-768x432.jpeg
2024-12-17 16:05
12K
PCC_Cyberbullying-and-Adolescent-MH-300x200.jpg
2024-12-20 16:49
12K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t3-181x300.png
2024-12-20 10:46
12K
PCC_Ferentz.jpg
2024-12-29 21:07
12K
JCP_Memantine-for-ADHD-300x200.jpg
2024-12-18 15:49
12K
IMG_0069-300x199.jpeg
2024-12-10 16:55
11K
JCP_care-and-research-in-ADHD-300x200.jpg
2024-12-18 15:49
11K
12-11-24_PTSD-300x200.jpeg
2024-12-11 16:51
11K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-t1-227x300.png
2024-12-03 08:52
11K
evolution-treatment-modalities-PTSD-24nr03767-t4.png
2024-12-11 12:06
11K
evolution-treatment-modalities-PTSD-24nr03767-t3.png
2024-12-11 11:52
11K
combined-cyproheptadine-dexamethasone-dependence-24cr03731-t1-300x190.png
2024-12-09 11:55
11K
12-19-24_Discipline-300x169.jpeg
2024-12-19 16:22
11K
JCP_Sex-Differences-in-Antidepressant-Acceptability-300x200.jpg
2024-12-03 22:32
11K
Pierre-N-Tariot1.jpg
2024-12-29 03:40
10K
12-12-24_Schizophrenia-300x200.jpeg
2024-12-12 15:51
10K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-f1-150x300.png
2024-12-20 10:46
9.9K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f3-300x192.png
2024-12-20 12:03
9.8K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-t2-261x300.png
2024-12-03 08:51
9.7K
differential-diagnoses-catatonia-clozapine-withdrawal-24cr03787-f1-300x268.png
2024-12-18 11:52
9.5K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t1-300x162.png
2024-12-18 12:24
9.4K
evolution-treatment-modalities-PTSD-24nr03767-t2-300x205.png
2024-12-11 11:52
9.3K
PCC_hypersensitivity-bupriopion-300x200.jpg
2024-12-11 23:42
9.2K
12-9-24_PTSD-300x178.jpeg
2024-12-09 18:38
9.2K
12-4-24_Music-300x225.jpeg
2024-12-04 18:14
9.2K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t3-100x100.png
2024-12-28 18:12
9.2K
JCP_Long-Term-Safety-Olanzapine-and-Samidorphan-300x200.jpg
2024-12-03 22:36
9.1K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f4-300x182.png
2024-12-20 12:03
9.0K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f2-220x300.png
2024-12-20 12:03
9.0K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t1-153x300.png
2024-12-20 10:46
8.9K
evolution-treatment-modalities-PTSD-24nr03767-t1-142x300.png
2024-12-11 11:52
8.9K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f3-300x244.png
2024-12-03 08:51
8.9K
PCC_Alzheimer-Dementia-FDG-PET-300x200.jpg
2024-12-16 03:00
8.9K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t2-300x132.png
2024-12-20 10:46
8.7K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t3-300x144.png
2024-12-18 12:27
8.7K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-t1-300x326.png
2024-12-20 12:03
8.7K
evolution-treatment-modalities-PTSD-24nr03767-f4.png
2024-12-11 11:52
8.5K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f1-150x150.png
2024-12-28 18:12
8.2K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t1-100x100.png
2024-12-28 18:12
8.2K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f2-300x156.png
2024-12-03 08:52
8.2K
12-16-24_post-partum-depression-300x206.jpeg
2024-12-16 15:16
8.2K
12-03.24_Schizophrenia-300x240.jpeg
2024-12-03 16:58
8.1K
PCC_Evolution-of-Treatment-for-PTSD-300x200.jpg
2024-12-09 18:25
8.0K
12-23-24_Holidays-150x150.jpeg
2024-12-23 19:49
7.9K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-t1-276x300.png
2024-12-20 12:03
7.8K
PCC_Tardive-Lingual-Dystonia-300x200.jpg
2024-12-20 16:49
7.8K
educational-intervention-mental-health-competency-24m03777-f1-148x300.png
2024-12-02 10:43
7.6K
12-1824_PTSD-150x150.jpeg
2024-12-18 17:34
7.4K
evolution-treatment-modalities-PTSD-24nr03767-t4-300x186.png
2024-12-11 12:06
7.3K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t2-100x100.png
2024-12-28 18:12
7.2K
evolution-treatment-modalities-PTSD-24nr03767-f3.png
2024-12-11 11:52
7.2K
12-02-24_Trauma-150x150.jpg
2024-12-02 20:05
7.1K
PCC_Mental-health-competency-150x150.jpg
2024-12-09 19:58
7.1K
12-13-24_dogs-150x150.jpeg
2024-12-13 17:45
7.1K
annalsfm_webcover.jpg
2024-12-02 19:48
7.1K
JCP_Sex-Differences-in-PTSD-1-150x150.jpg
2024-12-16 03:00
7.1K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t2-300x174.png
2024-12-17 11:49
6.9K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f2-100x100.png
2024-12-28 18:12
6.9K
JCP_Opioid-Industry-Legacy-1-300x200.jpg
2024-12-16 03:00
6.9K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-f1-300x235.png
2024-12-17 11:49
6.8K
JCP_Substance-use-and-ADHD-150x150.jpg
2024-12-18 15:49
6.7K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f1-150x150.png
2024-12-20 12:03
6.5K
12-20-24_Overpackaging-150x150.jpeg
2024-12-20 16:58
6.5K
evolution-treatment-modalities-PTSD-24nr03767-f2.png
2024-12-11 11:52
6.5K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t2-150x150.png
2024-12-18 10:26
6.3K
evolution-treatment-modalities-PTSD-24nr03767-f1.png
2024-12-11 11:52
6.3K
educational-intervention-mental-health-competency-24m03777-t2-300x153.png
2024-12-02 10:43
6.3K
PCC_BD-and-PTSD-150x150.jpg
2024-12-20 16:49
6.3K
PCC_Combined-Cyproheptadine-Dexamethasone-Dependence-150x150.jpg
2024-12-09 18:25
6.2K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t2-300x130.png
2024-12-18 12:27
6.2K
alzheimers-dementia-FDG-PET-neuropsychological-24cr03752-t1-300x113.png
2024-12-16 11:23
6.1K
JCP_care-and-research-in-ADHD-150x150.jpg
2024-12-18 15:49
6.1K
JCP_Sex-Differences-in-Antidepressant-Acceptability-150x150.jpg
2024-12-03 22:32
6.0K
evolution-treatment-modalities-PTSD-24nr03767-f3-300x270.png
2024-12-11 11:52
6.0K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t1-150x150.png
2024-12-17 11:49
5.9K
12-11-24_PTSD-150x150.jpeg
2024-12-11 16:51
5.8K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f1-300x138.png
2024-12-03 08:52
5.8K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f4-136x300.png
2024-12-03 08:51
5.8K
JCP_Memantine-for-ADHD-150x150.jpg
2024-12-18 15:49
5.7K
IMG_0069-150x150.jpeg
2024-12-10 16:55
5.6K
12-5-24_Depression-150x150.jpeg
2024-12-05 17:28
5.6K
12-19-24_Discipline-150x150.jpeg
2024-12-19 16:22
5.5K
PCC_Barkin.jpg
2024-12-29 20:56
5.5K
12-16-24_PTSD-150x150.jpeg
2024-12-16 19:44
5.5K
educational-intervention-mental-health-competency-24m03777-f1-150x150.png
2024-12-02 10:43
5.5K
PCC_Cyberbullying-and-Adolescent-MH-150x150.jpg
2024-12-20 16:49
5.5K
evolution-treatment-modalities-PTSD-24nr03767-f4-300x229.png
2024-12-11 11:52
5.5K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t1-150x150.png
2024-12-18 10:26
5.5K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t2-150x150.png
2024-12-20 10:46
5.4K
PCC_Alzheimer-Dementia-FDG-PET-150x150.jpg
2024-12-16 03:00
5.0K
Sex-Differences-PTSD-US-Military-Veterans-trauma-coping-social-factors-24br15621-t1-150x150.png
2024-12-14 12:24
4.9K
annalsfm_webcover-150x150.jpg
2024-12-02 19:48
4.9K
educational-intervention-mental-health-competency-24m03777-t1-150x150.png
2024-12-02 10:43
4.9K
PCC_hypersensitivity-bupriopion-150x150.jpg
2024-12-11 23:42
4.9K
12-9-24_PTSD-150x150.jpeg
2024-12-09 18:38
4.8K
PCC_Tardive-Lingual-Dystonia-150x150.jpg
2024-12-20 16:49
4.8K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f3-150x150.png
2024-12-03 08:51
4.8K
evolution-treatment-modalities-PTSD-24nr03767-f2-300x209.png
2024-12-11 11:52
4.7K
12-12-24_Schizophrenia-150x150.jpeg
2024-12-12 15:51
4.7K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f4-150x150.png
2024-12-20 12:03
4.6K
JCP_Long-Term-Safety-Olanzapine-and-Samidorphan-150x150.jpg
2024-12-03 22:36
4.5K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-f1-150x150.png
2024-12-20 10:46
4.5K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f3-150x150.png
2024-12-20 12:03
4.5K
12-23-24_Holidays-100x100.jpeg
2024-12-23 19:49
4.5K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t3-150x150.png
2024-12-20 10:46
4.4K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f1-100x100.png
2024-12-28 18:12
4.4K
Image-300x169.jpeg
2024-12-17 16:05
4.4K
12-4-24_Music-150x150.jpeg
2024-12-04 18:14
4.4K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-t2-150x150.png
2024-12-03 08:51
4.4K
evolution-treatment-modalities-PTSD-24nr03767-t1-150x150.png
2024-12-11 11:52
4.4K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t1-150x150.png
2024-12-18 12:24
4.3K
PCC_Evolution-of-Treatment-for-PTSD-150x150.jpg
2024-12-09 18:25
4.3K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t3-150x150.png
2024-12-18 12:27
4.2K
evolution-treatment-modalities-PTSD-24nr03767-t3-300x82.png
2024-12-11 11:52
4.2K
combined-cyproheptadine-dexamethasone-dependence-24cr03731-t1-150x150.png
2024-12-09 11:55
4.2K
evolution-treatment-modalities-PTSD-24nr03767-f1-150x150.png
2024-12-11 11:52
4.1K
12-1824_PTSD-100x100.jpeg
2024-12-18 17:34
4.1K
12-16-24_post-partum-depression-150x150.jpeg
2024-12-16 15:16
4.1K
PCC_Mental-health-competency-100x100.jpg
2024-12-09 19:58
4.1K
12-02-24_Trauma-100x100.jpg
2024-12-02 20:05
4.0K
JCP_Sex-Differences-in-PTSD-1-100x100.jpg
2024-12-16 03:00
3.9K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-t1-150x150.png
2024-12-03 08:52
3.9K
JCP_Substance-use-and-ADHD-100x100.jpg
2024-12-18 15:49
3.9K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t2-150x150.png
2024-12-18 12:27
3.8K
alzheimers-dementia-FDG-PET-neuropsychological-24cr03752-t1-150x150.png
2024-12-16 11:23
3.7K
PCC_BD-and-PTSD-100x100.jpg
2024-12-20 16:49
3.7K
12-13-24_dogs-100x100.jpeg
2024-12-13 17:45
3.7K
12-03.24_Schizophrenia-150x150.jpeg
2024-12-03 16:58
3.7K
differential-diagnoses-catatonia-clozapine-withdrawal-24cr03787-f1-150x150.png
2024-12-18 11:52
3.6K
JCP_care-and-research-in-ADHD-100x100.jpg
2024-12-18 15:49
3.6K
PCC_Combined-Cyproheptadine-Dexamethasone-Dependence-100x100.jpg
2024-12-09 18:25
3.5K
JCP_Opioid-Industry-Legacy-1-150x150.jpg
2024-12-16 03:00
3.5K
evolution-treatment-modalities-PTSD-24nr03767-f1-300x164.png
2024-12-11 11:52
3.5K
12-20-24_Overpackaging-100x100.jpeg
2024-12-20 16:58
3.5K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-f1-150x150.png
2024-12-17 11:49
3.5K
evolution-treatment-modalities-PTSD-24nr03767-t2-150x150.png
2024-12-11 11:52
3.4K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f1-100x100.png
2024-12-20 12:03
3.4K
Image-150x150.jpeg
2024-12-17 16:05
3.4K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t1-150x150.png
2024-12-20 10:46
3.4K
12-11-24_PTSD-100x100.jpeg
2024-12-11 16:51
3.4K
12-5-24_Depression-100x100.jpeg
2024-12-05 17:28
3.3K
PCC_Cyberbullying-and-Adolescent-MH-100x100.jpg
2024-12-20 16:49
3.3K
JCP_Sex-Differences-in-Antidepressant-Acceptability-100x100.jpg
2024-12-03 22:32
3.3K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t2-150x150.png
2024-12-17 11:49
3.3K
IMG_0069-100x100.jpeg
2024-12-10 16:55
3.3K
12-19-24_Discipline-100x100.jpeg
2024-12-19 16:22
3.2K
12-16-24_PTSD-100x100.jpeg
2024-12-16 19:44
3.2K
JCP_Memantine-for-ADHD-100x100.jpg
2024-12-18 15:49
3.2K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f1-150x150.png
2024-12-03 08:52
3.2K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f2-150x150.png
2024-12-20 12:03
3.2K
evolution-treatment-modalities-PTSD-24nr03767-t3-150x150.png
2024-12-11 11:52
3.2K
PCC_Alzheimer-Dementia-FDG-PET-100x100.jpg
2024-12-16 03:00
3.1K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t2-100x100.png
2024-12-18 10:26
3.0K
12-23-24_Holidays-94x64.jpeg
2024-12-23 19:49
3.0K
12-9-24_PTSD-100x100.jpeg
2024-12-09 18:38
3.0K
evolution-treatment-modalities-PTSD-24nr03767-t4-150x150.png
2024-12-11 12:06
2.9K
PCC_hypersensitivity-bupriopion-100x100.jpg
2024-12-11 23:42
2.9K
JCP_Long-Term-Safety-Olanzapine-and-Samidorphan-100x100.jpg
2024-12-03 22:36
2.8K
PCC_Mental-health-competency-94x64.jpg
2024-12-09 19:58
2.8K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f2-150x150.png
2024-12-03 08:52
2.8K
PCC_Tardive-Lingual-Dystonia-100x100.jpg
2024-12-20 16:49
2.8K
12-12-24_Schizophrenia-100x100.jpeg
2024-12-12 15:51
2.7K
annalsfm_webcover-100x100.jpg
2024-12-02 19:48
2.7K
12-4-24_Music-100x100.jpeg
2024-12-04 18:14
2.7K
12-02-24_Trauma-94x64.jpg
2024-12-02 20:05
2.7K
PCC_BD-and-PTSD-94x64.jpg
2024-12-20 16:49
2.7K
PCC_Evolution-of-Treatment-for-PTSD-100x100.jpg
2024-12-09 18:25
2.7K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t1-100x100.png
2024-12-17 11:49
2.7K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f3-100x100.png
2024-12-20 12:03
2.7K
12-1824_PTSD-94x64.jpeg
2024-12-18 17:34
2.7K
JCP_Substance-use-and-ADHD-94x64.jpg
2024-12-18 15:49
2.6K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t2-100x100.png
2024-12-20 10:46
2.6K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f4-150x150.png
2024-12-03 08:51
2.6K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f4-100x100.png
2024-12-20 12:03
2.6K
PCC_Combined-Cyproheptadine-Dexamethasone-Dependence-94x64.jpg
2024-12-09 18:25
2.6K
12-16-24_post-partum-depression-100x100.jpeg
2024-12-16 15:16
2.6K
JCP_Sex-Differences-in-PTSD-1-94x64.jpg
2024-12-16 03:00
2.5K
PCC_Cyberbullying-and-Adolescent-MH-94x64.jpg
2024-12-20 16:49
2.5K
educational-intervention-mental-health-competency-24m03777-t1-100x100.png
2024-12-02 10:43
2.5K
12-5-24_Depression-94x64.jpeg
2024-12-05 17:28
2.5K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t3-100x100.png
2024-12-20 10:46
2.5K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f1-94x64.png
2024-12-20 12:03
2.4K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t1-100x100.png
2024-12-18 10:26
2.4K
evolution-treatment-modalities-PTSD-24nr03767-f4-150x150.png
2024-12-11 11:52
2.4K
evolution-treatment-modalities-PTSD-24nr03767-t1-100x100.png
2024-12-11 11:52
2.4K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-f1-100x100.png
2024-12-20 10:46
2.3K
12-13-24_dogs-94x64.jpeg
2024-12-13 17:45
2.3K
12-20-24_Overpackaging-94x64.jpeg
2024-12-20 16:58
2.3K
12-19-24_Discipline-94x64.jpeg
2024-12-19 16:22
2.3K
Sex-Differences-PTSD-US-Military-Veterans-trauma-coping-social-factors-24br15621-t1-100x100.png
2024-12-14 12:24
2.3K
JCP_care-and-research-in-ADHD-94x64.jpg
2024-12-18 15:49
2.3K
Image-100x100.jpeg
2024-12-17 16:05
2.3K
JCP_Opioid-Industry-Legacy-1-100x100.jpg
2024-12-16 03:00
2.3K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-t1-100x100.png
2024-12-03 08:52
2.3K
12-11-24_PTSD-94x64.jpeg
2024-12-11 16:51
2.3K
12-16-24_PTSD-94x64.jpeg
2024-12-16 19:44
2.2K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f3-100x100.png
2024-12-03 08:51
2.2K
12-03.24_Schizophrenia-100x100.jpeg
2024-12-03 16:58
2.2K
educational-intervention-mental-health-competency-24m03777-f1-100x100.png
2024-12-02 10:43
2.2K
IMG_0069-94x64.jpeg
2024-12-10 16:55
2.2K
educational-intervention-mental-health-competency-24m03777-t2-150x150.png
2024-12-02 10:43
2.2K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-t2-100x100.png
2024-12-03 08:51
2.2K
combined-cyproheptadine-dexamethasone-dependence-24cr03731-t1-100x100.png
2024-12-09 11:55
2.2K
12-9-24_PTSD-94x64.jpeg
2024-12-09 18:38
2.2K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-t1-150x150.png
2024-12-20 12:03
2.2K
JCP_Memantine-for-ADHD-94x64.jpg
2024-12-18 15:49
2.1K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-f1-100x100.png
2024-12-17 11:49
2.1K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t3-100x100.png
2024-12-18 12:27
2.1K
JCP_Long-Term-Safety-Olanzapine-and-Samidorphan-94x64.jpg
2024-12-03 22:36
2.1K
PCC_Alzheimer-Dementia-FDG-PET-94x64.jpg
2024-12-16 03:00
2.0K
JCP_Sex-Differences-in-Antidepressant-Acceptability-94x64.jpg
2024-12-03 22:32
2.0K
PCC_hypersensitivity-bupriopion-94x64.jpg
2024-12-11 23:42
2.0K
alzheimers-dementia-FDG-PET-neuropsychological-24cr03752-t1-100x100.png
2024-12-16 11:23
2.0K
12-12-24_Schizophrenia-94x64.jpeg
2024-12-12 15:51
2.0K
12-4-24_Music-94x64.jpeg
2024-12-04 18:14
2.0K
evolution-treatment-modalities-PTSD-24nr03767-f3-150x150.png
2024-12-11 11:52
2.0K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t2-94x64.png
2024-12-18 10:26
2.0K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t1-100x100.png
2024-12-18 12:24
1.9K
PCC_Evolution-of-Treatment-for-PTSD-94x64.jpg
2024-12-09 18:25
1.9K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t1-94x64.png
2024-12-17 11:49
1.9K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t1-100x100.png
2024-12-20 10:46
1.8K
12-16-24_post-partum-depression-94x64.jpeg
2024-12-16 15:16
1.8K
annalsfm_webcover-94x64.jpg
2024-12-02 19:48
1.8K
educational-intervention-mental-health-competency-24m03777-f1-94x64.png
2024-12-02 10:43
1.8K
evolution-treatment-modalities-PTSD-24nr03767-t2-100x100.png
2024-12-11 11:52
1.8K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t3-94x64.png
2024-12-20 16:59
1.8K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f3-94x64.png
2024-12-20 12:03
1.8K
JCP_Opioid-Industry-Legacy-1-94x64.jpg
2024-12-16 03:00
1.7K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t2-94x64.png
2024-12-20 16:59
1.7K
evolution-treatment-modalities-PTSD-24nr03767-f2-150x150.png
2024-12-11 11:52
1.7K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t2-100x100.png
2024-12-17 11:49
1.7K
differential-diagnoses-catatonia-clozapine-withdrawal-24cr03787-f1-100x100.png
2024-12-18 11:52
1.7K
PCC_Tardive-Lingual-Dystonia-94x64.jpg
2024-12-20 16:49
1.7K
educational-intervention-mental-health-competency-24m03777-t1-94x64.png
2024-12-02 10:43
1.7K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t3-94x64.png
2024-12-20 10:46
1.6K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-f1-94x64.png
2024-12-20 10:46
1.6K
evolution-treatment-modalities-PTSD-24nr03767-t1-94x64.png
2024-12-11 11:52
1.6K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t2-100x100.png
2024-12-18 12:27
1.6K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t2-94x64.png
2024-12-20 10:46
1.6K
12-03.24_Schizophrenia-94x64.jpeg
2024-12-03 16:58
1.6K
combined-cyproheptadine-dexamethasone-dependence-24cr03731-t1-94x64.png
2024-12-09 11:55
1.6K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-t1-94x64.png
2024-12-20 16:59
1.6K
Sex-Differences-PTSD-US-Military-Veterans-trauma-coping-social-factors-24br15621-t1-94x64.png
2024-12-14 12:24
1.6K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f2-100x100.png
2024-12-20 12:03
1.6K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f4-100x100.png
2024-12-03 08:51
1.6K
Maternal-Cannabis-Use-Pregnancy-Autism-Spectrum-Disorder-Attention-Deficit-Hyperactivity-Disorder-Offspring-t1-94x64.png
2024-12-18 10:26
1.5K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f1-100x100.png
2024-12-03 08:52
1.5K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f4-94x64.png
2024-12-20 12:03
1.5K
evolution-treatment-modalities-PTSD-24nr03767-t3-100x100.png
2024-12-11 11:52
1.5K
Image-94x64.jpeg
2024-12-17 16:05
1.5K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t3-94x64.png
2024-12-18 12:27
1.5K
evolution-treatment-modalities-PTSD-24nr03767-f3-94x64.png
2024-12-11 11:52
1.4K
evolution-treatment-modalities-PTSD-24nr03767-t2-94x64.png
2024-12-11 11:52
1.4K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t1-94x64.png
2024-12-18 12:24
1.4K
educational-intervention-mental-health-competency-24m03777-t2-100x100.png
2024-12-02 10:43
1.4K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f1-94x64.png
2024-12-03 08:52
1.4K
evolution-treatment-modalities-PTSD-24nr03767-t4-100x100.png
2024-12-11 12:06
1.3K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-f1-94x64.png
2024-12-17 11:49
1.3K
evolution-treatment-modalities-PTSD-24nr03767-t4-94x64.png
2024-12-11 12:06
1.3K
evolution-treatment-modalities-PTSD-24nr03767-f4-94x64.png
2024-12-11 11:52
1.3K
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-t1-100x100.png
2024-12-20 12:03
1.3K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f2-100x100.png
2024-12-03 08:52
1.2K
evolution-treatment-modalities-PTSD-24nr03767-f4-100x100.png
2024-12-11 11:52
1.2K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-t1-94x64.png
2024-12-03 08:52
1.2K
socioeconomic-disparities-substance-opioid-use-disorders-IBD-hospitalizations-24m15339-t1-94x64.png
2024-12-20 10:46
1.2K
evolution-treatment-modalities-PTSD-24nr03767-f2-100x100.png
2024-12-11 11:52
1.2K
evolution-treatment-modalities-PTSD-24nr03767-f3-100x100.png
2024-12-11 11:52
1.2K
educational-intervention-mental-health-competency-24m03777-t2-94x64.png
2024-12-02 10:43
1.1K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f2-94x64.png
2024-12-20 16:59
1.1K
alzheimers-dementia-FDG-PET-neuropsychological-24cr03752-t1-94x64.png
2024-12-16 11:23
1.1K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f4-94x64.png
2024-12-03 08:51
1.1K
comorbid-bipolar-disorder-posttraumatic-stress-disorder-24f03768-t2-94x64.png
2024-12-17 11:49
1.1K
evolution-treatment-modalities-PTSD-24nr03767-f1-100x100.png
2024-12-11 11:52
1.1K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-t2-94x64.png
2024-12-03 08:51
1.1K
differential-diagnoses-catatonia-clozapine-withdrawal-24cr03787-f1-94x64.png
2024-12-18 11:52
1.1K
evolution-treatment-modalities-PTSD-24nr03767-t3-94x64.png
2024-12-11 11:52
1.1K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f3-94x64.png
2024-12-03 08:51
1.1K
evolution-treatment-modalities-PTSD-24nr03767-f1-94x64.png
2024-12-11 11:52
1.0K
Treatments-Predictors-Substance-Use-Disorders-Attention-Deficit-Hyperactivity-Disorder-INCAS-24m15494-t2-94x64.png
2024-12-18 12:27
1.0K
Long-Term-Safety-Tolerability-Treatment-Effect-Olanzapine-Samidorphan-4-Year-Open-Label-Study-24m15511-f2-94x64.png
2024-12-03 08:52
1.0K
olanzapine-samidorphan-effects-weight-gain-meta-analysis-phase-2-3-randomized-double-blind-studies-24m15526-f1-94x64.png
2024-12-20 16:59
933
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-f2-94x64.png
2024-12-20 12:03
932
evolution-treatment-modalities-PTSD-24nr03767-f2-94x64.png
2024-12-11 11:52
900
efficacy-safety-memantine-children-adults-ADHD-glutamate-dopamine-24r15507-t1-94x64.png
2024-12-20 12:03
728
Apache/2.4.41 (Ubuntu) Server at www.psychiatrist.com Port 443